Optimind Pharma Corp.
Optimind Pharma Corp. (OMND.CN) Revenue
Annual & quarterly revenue history · segment & region breakdown
OMND.CN · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsOptimind Pharma Corp. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Optimind Pharma Corp. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Optimind Pharma Corp. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Optimind Pharma Corp.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
OMND.CN revenue · 4 questionsOMND.CN's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Optimind Pharma Corp. SEC filings · GAAP · Optimind Pharma Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026